Kawasaki disease: pathophysiology and insights from mouse models | Nature Reviews Rheumatology
Kawasaki Disease
Abstract 134: Early Immunoglogulin Therapy and Outcomes of Kawasaki Disease | Circulation
Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature | Italian Journal of Pediatrics | Full Text
Recurrent Kawasaki disease presenting as acute airway obstruction
Kawasaki disease: insights into pathogenesis and approaches to treatment | Nature Reviews Rheumatology
Kawasaki disease in children: Epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years
Is it Kawasaki Disease or Multisystem Inflammatory Syndrome in Children? - ScienceDirect
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Frontiers | The Epidemiology and Pathogenesis of Kawasaki Disease
Late Treatment and Recurrence of Kawasaki Disease in a Moroccan Infant
Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram
Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease | Scientific Reports
Frontiers | How Should We Classify Kawasaki Disease?
Clinical characteristics of patients with recurrent Kawasaki disease: a nationwide cohort study of 19 456 patients with minimum 3-year follow up | Archives of Disease in Childhood
Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation
Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study
Frontiers | Epidemiology of Kawasaki Disease in Europe
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal of the American Heart Association
Mortality among Children with Kawasaki Disease in Japan | NEJM
The up‐to‐date pathophysiology of Kawasaki disease - Hara - 2021 - Clinical & Translational Immunology - Wiley Online Library
Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution | PLOS ONE
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks | Italian Journal of Pediatrics | Full Text
Long-term Consequences of Kawasaki Disease | Circulation
